-
1
-
-
0029844258
-
The management of Hodgkin's disease: Half a century of change. The Kaplan memorial lecture
-
Rosenberg S. The management of Hodgkin's disease: half a century of change. The Kaplan memorial lecture. Ann Oncol 1996; 7: 555-560.
-
(1996)
Ann. Oncol.
, vol.7
, pp. 555-560
-
-
Rosenberg, S.1
-
2
-
-
0037089650
-
Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger
-
Ng AK, Bernardo MP, Weller E et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002; 20: 2101-2108.
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 2101-2108
-
-
Ng, A.K.1
Bernardo, M.P.2
Weller, E.3
-
3
-
-
0142121297
-
Long-term cause-specific mortality of patients treated for Hodgkin's disease
-
Aleman BM, van den Belt-Dusebout AW, Klokman WJ et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003; 21: 3431-3439.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 3431-3439
-
-
Aleman, B.M.1
van den Belt-Dusebout, A.W.2
Klokman, W.J.3
-
4
-
-
0026447595
-
Second cancer after the treatment for Hodgkin's disease: A report from the International Database on Hodgkin's Disease
-
Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease. Ann Oncol 1992; 3(Suppl 4): 117-128.
-
(1992)
Ann. Oncol.
, vol.3
, Issue.SUPPL. 4
, pp. 117-128
-
-
Henry-Amar, M.1
-
5
-
-
0023835089
-
Risk of second cancers after treatment for Hodgkin's disease
-
Tucker M, Coleman C, Cox R. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988; 318: 76-81.
-
(1988)
N. Engl. J. Med.
, vol.318
, pp. 76-81
-
-
Tucker, M.1
Coleman, C.2
Cox, R.3
-
6
-
-
0028329713
-
Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage
-
van Leeuwen FE, Chorus AM, van den Belt-Dusebout AW et al. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. J Clin Oncol 1994; 12: 1063-1073.
-
(1994)
J. Clin. Oncol.
, vol.12
, pp. 1063-1073
-
-
van Leeuwen, F.E.1
Chorus, A.M.2
van den Belt-Dusebout, A.W.3
-
7
-
-
0142058040
-
Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: A report from the German Hodgkin's Lymphoma Study Group
-
Josting A, Wiedenmann S, Franklin J et al. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2003; 21: 3440-3446.
-
(2003)
J. Clin. Oncol.
, vol.21
, pp. 3440-3446
-
-
Josting, A.1
Wiedenmann, S.2
Franklin, J.3
-
8
-
-
0035300679
-
Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: Incidence, treatment, and prognosis
-
Rueffer U, Josting A, Franklin J et al. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis. J Clin Oncol 2001; 19: 2026-2032.
-
(2001)
J. Clin. Oncol.
, vol.19
, pp. 2026-2032
-
-
Rueffer, U.1
Josting, A.2
Franklin, J.3
-
9
-
-
0031927630
-
The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment
-
Enrici R, Anselmo A, Iacari V et al. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment. Haematologica. 1998; 83: 636-644.
-
(1998)
Haematologica
, vol.83
, pp. 636-644
-
-
Enrici, R.1
Anselmo, A.2
Iacari, V.3
-
10
-
-
33845382806
-
Nonparametric estimation from incomplete observations
-
Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 34: 457-464.
-
(1958)
J. Am. Stat. Assoc.
, vol.34
, pp. 457-464
-
-
Kaplan, E.1
Meier, P.2
-
11
-
-
0033952110
-
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
-
van Leeuwen FE, Klokman WJ, Veer MB et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000; 18: 487-497.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 487-497
-
-
van Leeuwen, F.E.1
Klokman, W.J.2
Veer, M.B.3
-
12
-
-
0033974306
-
Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment
-
Swerdlow AJ, Barber JA, Hudson GV et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000; 18: 498-509.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 498-509
-
-
Swerdlow, A.J.1
Barber, J.A.2
Hudson, G.V.3
-
13
-
-
0037102360
-
Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years
-
Dores GM, Metayer C, Curtis RE et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002; 20: 3484-3494.
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 3484-3494
-
-
Dores, G.M.1
Metayer, C.2
Curtis, R.E.3
-
14
-
-
0034088026
-
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence
-
Metayer C, Lynch CF, Clarke EA et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000; 18: 2435-2443.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 2435-2443
-
-
Metayer, C.1
Lynch, C.F.2
Clarke, E.A.3
-
15
-
-
0034128929
-
Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence
-
Green DM, Hyland A, Barcos MP et al. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence. J Clin Oncol 2000; 18: 1492-1499.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 1492-1499
-
-
Green, D.M.1
Hyland, A.2
Barcos, M.P.3
-
16
-
-
0036862103
-
Long-term risk of second malignancy after treatment of Hodgkin's disease: The influence of treatment, age and follow-up time
-
Foss Abrahamsen A, Andersen A, Nome O et al. Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. Ann Oncol 2002; 13: 1786-1791.
-
(2002)
Ann. Oncol.
, vol.13
, pp. 1786-1791
-
-
Foss Abrahamsen, A.1
Andersen, A.2
Nome, O.3
-
17
-
-
0342905432
-
Second malignancies after Hodgkin's disease: The Munich experience
-
Munker R, Grutzner S, Hiller E et al. Second malignancies after Hodgkin's disease: the Munich experience. Ann Hematol 1999; 78: 544-554.
-
(1999)
Ann. Hematol.
, vol.78
, pp. 544-554
-
-
Munker, R.1
Grutzner, S.2
Hiller, E.3
-
18
-
-
0029877511
-
Breast cancer and other second neoplasms after childhood Hodgkin's disease
-
[see comments]
-
Bhatia S, Robison L, Oberlin O et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996; 334: 745-751 [see comments].
-
(1996)
N. Engl. J. Med.
, vol.334
, pp. 745-751
-
-
Bhatia, S.1
Robison, L.2
Oberlin, O.3
-
19
-
-
0041963074
-
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease
-
van Leeuwen FE, Klokman WJ, Stovall M et al. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 2003; 95: 971-980.
-
(2003)
J. Natl. Cancer Inst.
, vol.95
, pp. 971-980
-
-
van Leeuwen, F.E.1
Klokman, W.J.2
Stovall, M.3
-
21
-
-
0026482443
-
Lung cancer following Hodgkin's disease: A case-control study
-
Kaldor J, Day N, Bell J et al. Lung cancer following Hodgkin's disease: a case-control study. Int J Cancer 1992; 52: 677-681.
-
(1992)
Int. J. Cancer
, vol.52
, pp. 677-681
-
-
Kaldor, J.1
Day, N.2
Bell, J.3
-
22
-
-
0026560447
-
Risk of second primary cancers after Hodgkin's disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation
-
Swerdlow A, Douglas A, Hudson G et al. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. Br Med J 1992; 304: 1137-1143.
-
(1992)
Br. Med. J.
, vol.304
, pp. 1137-1143
-
-
Swerdlow, A.1
Douglas, A.2
Hudson, G.3
-
23
-
-
0028154066
-
Second cancer risk following Hodgkin's disease: A 20-year follow-up study
-
van Leeuwen FE, Klokman WJ, Hagenbeek A et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 1994; 12: 312-325.
-
(1994)
J. Clin. Oncol.
, vol.12
, pp. 312-325
-
-
van Leeuwen, F.E.1
Klokman, W.J.2
Hagenbeek, A.3
-
24
-
-
0037105618
-
Second malignancy after Hodgkin's disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors
-
Ng AK, Bernardo MV, Weller E et al. Second malignancy after Hodgkin's disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood 2002; 100: 1989-1996.
-
(2002)
Blood
, vol.100
, pp. 1989-1996
-
-
Ng, A.K.1
Bernardo, M.V.2
Weller, E.3
-
25
-
-
0031405592
-
Breast cancer in patients treated for Hodgkin's disease: Clinical and pathological analysis of 76 cases in 63 patients
-
Cutuli B, Dhermain F, Borel C et al. Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients. Eur J Cancer 1997; 33: 2315-2320.
-
(1997)
Eur. J. Cancer
, vol.33
, pp. 2315-2320
-
-
Cutuli, B.1
Dhermain, F.2
Borel, C.3
-
26
-
-
1842287357
-
Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome
-
Mauch P, Kalish L, Marcus K et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood 1996; 87: 3625-3632.
-
(1996)
Blood
, vol.87
, pp. 3625-3632
-
-
Mauch, P.1
Kalish, L.2
Marcus, K.3
-
27
-
-
0027082879
-
Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients
-
[see comments]
-
Yahalom J, Petrek J, Biddinger P et al. Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992; 10: 1674-1681 [see comments].
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 1674-1681
-
-
Yahalom, J.1
Petrek, J.2
Biddinger, P.3
-
28
-
-
0031972611
-
Current perspectives on radiation-induced breast cancer
-
[see comments]
-
Goss P, Sierra S. Current perspectives on radiation-induced breast cancer. J Clin Oncol 1998; 16: 338-347[see comments].
-
(1998)
J. Clin. Oncol.
, vol.16
, pp. 338-347
-
-
Goss, P.1
Sierra, S.2
-
29
-
-
0027057038
-
Radiation-associated breast cancer after Hodgkin's disease: Risks and screening in perspective
-
[editorial; comment]
-
Shapiro C, Mauch P. Radiation-associated breast cancer after Hodgkin's disease: risks and screening in perspective. J Clin Oncol 1992; 10: 1662 -1665[editorial; comment].
-
(1992)
J. Clin. Oncol.
, vol.10
, pp. 1662-1665
-
-
Shapiro, C.1
Mauch, P.2
-
30
-
-
0037028736
-
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
-
Travis LB, Gospodarowicz M, Curtis RE et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002; 94: 182-192.
-
(2002)
J. Natl. Cancer Inst.
, vol.94
, pp. 182-192
-
-
Travis, L.B.1
Gospodarowicz, M.2
Curtis, R.E.3
|